VAV3 in human cancers: Mechanism and clinical implication
Sulieman Ibraheem Shelash Al-Hawary1, Ali Alsalamy2, Reena Gupta3
1Departemnt of Business Administration, Business School, Al-Bayt University, P.O.BOX 130040, Mafraq 25113, Jordan.
Pathology, Research and Practice
|July 19, 2023
Summary
VAV3, a Guanine nucleotide exchange factor (GEF), promotes cancer progression by enhancing cell proliferation, survival, and invasion. This review explores VAV3
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Guanine nucleotide exchange factors (GEFs) regulate signal transduction pathways by activating GTPases.
- The VAV family of GEFs acts as crucial mediators in cellular signaling, functioning as phosphorylation-dependent molecular switches.
- VAV3 has emerged as a protein implicated in various human cancers, with elevated levels suggesting an oncogenic role.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying VAV3's role in cancer progression.
- To review the prognostic value of VAV3 as a biomarker in human cancers.
- To assess VAV3's potential as a mediator of chemoresistance in cancer treatment.
Main Methods:
- Literature review of existing studies on VAV3 in cancer.
- Analysis of data linking VAV3 expression levels to cancer progression and patient outcomes.
- Investigation into VAV3's functional roles in cellular processes relevant to cancer, such as proliferation, migration, and apoptosis.
Main Results:
- VAV3 promotes key oncogenic processes including cell proliferation, epithelial-mesenchymal transition (EMT), colony formation, cell cycle progression, survival, migration, and invasion.
- VAV3 suppresses cancer cell apoptosis, contributing to tumor growth and resistance to therapy.
- Elevated VAV3 levels correlate with cancer progression and may serve as a prognostic indicator.
Conclusions:
- VAV3 plays a significant oncogenic role in human cancers by promoting tumor growth and metastasis.
- VAV3 holds potential as a prognostic biomarker for cancer patients.
- VAV3 may be a critical mediator of chemoresistance, suggesting its potential as a therapeutic target.
More Related Videos
Related Concept Videos
01:51Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:41Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K